Deploy the expanded sales force
Deadline passed; outcome being checked
- Announced
- 24 Mar 2026
- Due
- 30 Jun 2026
- Status
- Checking
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“The expanded sales force is expected to be fully deployed in Q2 2026.”
What we found
The deadline has passed. We check for public evidence starting 30 days after the deadline, and repeat the check if nothing clear turns up.
Commitment lineage
Every time the company restated this commitment. The original is never changed, and the outcome is always measured against version 1.
- 2 versions
-
Version 1 · original · stated 24 Mar 2026
Deadline 30 Jun 2026 (“Q2 2026”) · wording expected
-
Version 2 · stated 11 May 2026
Deadline 30 Jun 2026 (“by the end of Q2 2026”) · target 117 territories · wording expected
“LENZ is expanding its sales force... to 117 territories. The expanded sales force is expected to be fully deployed by the end of Q2 2026.”
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Rollout
- Indicative materiality
- Low rules
- Action
- Deploy
- Deliverable
- Expanded sales force
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
Tell me what happens
This deadline has not been settled yet. We check 30 days after it passes. Get an email when we record the outcome.
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- OutcomeNot yet assessed. Nothing is judged before the deadline.
Are you LENZ Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2026-LENZ-003375 · Corrections policy